Adagio Medical Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Adagio Medical Holdings, Inc. (ADGM) on March 17, 2025, covering events occurring on March 11, 2025. The Company is an emerging growth company incorporated in Delaware and trades on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on corporate governance and personnel changes.
Material Changes
- Executive Departure: John Dahldorf, Chief Financial Officer (CFO), announced his resignation effective March 21, 2025.
- Reason for Departure: The resignation is not the result of any dispute or disagreement regarding financial reporting, accounting policies, procedures, estimates, or judgments.
- Succession: The Company has initiated a search for a new Chief Financial Officer.
Guidance, Outlook, and Risks
The filing references a press release dated March 17, 2025 (Exhibit 99.1) containing business updates, but the text of this 8-K does not provide specific guidance, outlook, or risk factors beyond the leadership transition. The information regarding the press release is furnished and not deemed "filed" for Section 18 liability purposes.
Investor Verification Checklist
- Verify the timeline for the appointment of a new Chief Financial Officer.
- Review the full text of the March 17, 2025 press release (Exhibit 99.1) for additional business updates not detailed in this summary.
- Monitor upcoming filings for any interim financial reporting arrangements during the CFO transition.